February 08, 2023 article Open access Immune abnormalities in IgA nephropathy Clinical Kidney Journal DOI: 10.1093/ckj/sfad025 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 1 stored of 72 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Beyond galactose-deficient IgA1: reconsidering IgA2 as a pathogenic driver in IgA nephropathy 2026 Kidney International article Medicine Renal Diseases and Glomerulopathies 0 citations 1 result References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy 2022 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 226 citations Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy 2020 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access cited by 18 patents 161 citations How I Treat IgA Nephropathy 2022 Clinical Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access 14 citations IgA-Nephropathie 2020 Der Nephrologe article Medicine Renal Diseases and Glomerulopathies 4 citations 4 results